Skip to main content

Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?

By Los Angeles Times  
   May 31, 2024

Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.